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where AM is the reversible protein-modifying agent adsorptive complex, the first-order reaction of which results in the production of modified protein, and where k , , , k + , , k -,, k -2, k+,, and k -, are the relevant binding and modification rate constants. It has been shown that the free energy change difference between reactions (1) and ( 2 ) , at t=O, AAG(,.2) ( t = 0), where t is reaction time, is (Rakitzis, 1983 (Rakitzis, , 1987 : + R T l n ( k + , / K i k + a ) (3) where AAG,,(,,zi is the standard free energy change difference between reactions (1) and ( 2 ) , and where K, is defined as k -, / k + ,. It will be noted that k , , / K , k , , is equal to the rate enhancement obtained at t = 0, when the rate of the protein modification reaction is compared with the rate of the model compound modification reaction. Proceeding from first principles, the standard free energy change difference between reactions (1) and (2) is given by the relationship:
To determine the maximum extent of protein modification rate enhancement, when all of the free energy of the reversible protein-modifying agent complex is utilized towards the rate increase of covalent protein modification, the following constraints are imposed on the reaction system of eqns. (1) and (2). (i) A thermodynamic constraint, namely that the AA GI,, I , , ) value of eqn. (3) is equal to zero. This follows from the assumption that reactions (1) and (2) have the same reactants, and the same products, since any reversible protein-modifying agent bonds, formed in the course of the reaction, are utilized towards the rate increase of protein covalent modification (Rakitzis, 1987) . Accordingly, for a given K, value a unique value for k , , / k -, is specified. (ii) The kinetic constraints imposed by the model of eqn. (1). These are as follows. The reaction of eqn. (1) Since a protein modification reaction with a specified K i value necessarily is a reaction described by a single exponential function of reaction time (Kitz & Wilson, 1962) , the conditions must be sought under which eqn. ( 5 ) reduces to a single exponential equation. These conditions are (a) that C, reduces to zero; however, since C, (Frost & Pearson, 1961) , it follows that C, tends to zero as k -, tends to zero; (b) that either C, or C3 reduces to zero, the necessary and sufficient condition for which is that k -, P k + ,[MI, k , , (a requirement of the steadystate approximation; Brocklehurst, 1979; Rakitzis, 1980 Rakitzis, , 1984 . To these the assumption must be added that the value for k , , may reasonably be accepted, for most protein modification reactions, to be close to that of a diffusion-controlled reaction, i.e. close to lo8 M-Is-' (Brocklehurst, 1979) . By the application of these constraints and assumptions to a protein modification reaction with a given K , value, it is possible to assign to this reaction, by numerical computation, an approximate upper limit for the value of k + , . The k + , / K i k + , value, derived from this computed k , , value will represent the maximum extent of rate enhancement, i.e. the rate enhancement obtained when all of the binding energy of the protein-modifying agent adsorptive complex is utilized towards the rate increase of protein covalent modification. Analysis of bile acids in serum has been shown to provide a sensitive index for the diagnosis and epidemiology of various diseases including those of the hepatobiliary system (Setchell & Matsui, 1983) . Individual bile acids and their different conjugated forms can be quantified by h.p.l.c., but their determination in serum is difficult, since they are present in Abbreviation used: 3 a-HSD, 3a-hydroxysteroid dehydrogenase.
low concentrations and have low u.v.-absorption coefficients in the near-u.v.-visible range of the spectrum (Parris, 1977) . Their photometric response can be enhanced by derivatization with a u.v.-absorbing chromophore (Parris, 1979; Mingrone & Greco, 1980) or by formation of ion-pairs using ion-pair chromatography (Wildgrube et al., Swobodnik et al., 1985) . Alternatively, the bile acids can be quantified indirectly using 3a-hydroxysteroid dehydrogenase (3a-HSD), whereby NADH, produced as a result of oxidation of the 3a-hydroxyl group on the bile acid nucleus, is detected using spectrofluorimetry (Arisue et al., 1980) . In this communication we have compared these three procedures in order to establish the most sensitive method for determination of bile acids in serum.
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(1) The glycine conjugates of cholic, chenodeoxycholic and deoxycholic acid were derivatized with p-bromophenacyl bromide (1O:l molar excess) in the presence of 18-crown-6 ether. Derivatization methods suffer from a variety of drawbacks including co-elution of the bile acid derivatives and interference from products of the derivatization reaction (Street et a/., 1983) . We were unable to modify the mobile phase in order to separate the bile acid derivatives from other compounds in the sample. Consequently, a purification step on silica gel was necessary before h.p.1.c. The chromatographic conditions used were as follows: methanol/0.3% (w/v) aqueous ammonium dihydrogen phosphate (73:27, v/v), pH 3.8, flow rate 1.0 ml/min on a p-Bondapak C18 column (Waters). Absorbance at 254 nm was measured giving a lower limit of detection of 100 ng of each bile acid derivative. This method was not suitable for taurine conjugates, since the reaction requires a free carboxylic group.
(2) Ion-pair chromatography using tetrabutylammonium hydrogen sulphate as counter ion during h.p.1.c. on a Spherisorb ODS column resulted in detection of 100 ng of glycine and taurine conjugates of cholic, chenodeoxycholic, deoxycholic and lithocholic acid at 200 nm. The mobile phase consisted of methanol/0.3% (w/v) aqueous ammonium dihydrogen phosphate (7 1:29, v/v), pH 5.5 containing tetrabutylammonium hydrogen sulphate (200 mg/l). Sensitivity was adequate for the detection of bile acid conjugates in serum, but it was unsuitable for the quantification of free bile acids, since they possessed lower u.v.-absorption coefficients.
(3) Spectrofluorimetric detection of NADH produced during oxidation of bile acids by immobilized 3a-HSD provided the best results. The following chromatographic conditions were developed to obtain optimum analysis of the bile acids and their conjugates (Campbell et al., 1989) . Mobile phase A was methanol/0.3% (w/v) aqueous ammonium dihydrogen phosphate buffer, pH 5.5 (73:27, v/v) , whereas mobile phase B had the same solutions but in the respective proportions 82: 18 (v/v). NAD ( 1.4 mM) was incorporated in both mobile phases. Flow rate was 0.5 ml/min. The solvent programme was 100% mobile phase A at time zero, changing to 100% B at a rate of 2%/min and remaining at 100% B for 30 min. The eluate from the Spherisorb ODS column was modified by means of a second buffer [3.0% (w/v) aqueous ammonium dihydrogen phosphate, pH 6.5 containing 1.4 mM-NAD, 0.3-sodium a i d e and 1.0 mM-EDTA which was pumped at 0.5 ml/min into the system via a T-piece junction using a second pump. It then flowed through a column (2.5 m m X 100 mm) of 3a-HSD immobilized on aminopropyl glass beads. NADH produced during oxidation of the bile acid peaks was detected spectrofluorimetricdly (extinction 338 nm, emission 425 MI ) . The limit of detection was less than 50 ng for each bile acid. The 12 major diagnostic bile acids could be separated on a single chromatogram (Fig. 1 a) . This method possesses considerable screening potential since free acids may be quantitatively more important than was previously believed (Setchell et al., 1982) and fractionation of the sample into free bile acids and glycine and taurine conjugated groups before h.p.1.c. as carried out by Kamada et al. (1982) was not required. A typical chromato- gram showing the separation of bile acids from a normal human serum sample (0.25 ml) is shown in Fig. 1( b ) .
